Graft versus host disease following liver transplantation: A case report

Zhang,Changsong; Yang,Guangshun; Ling,Yang; Chen,Guihua; Zhou,Tianbao

doi:10.3892/etm.2014.1850

October 2014 Volume 8 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October 2014 Volume 8 Issue 4

Full Size Image

Case Report

Graft versus host disease following liver transplantation: A case report

Authors:
- Changsong Zhang
- Guangshun Yang
- Yang Ling
- Guihua Chen
- Tianbao Zhou
View Affiliations / Copyright

Affiliations: Clinical Oncology Laboratory, Changzhou Tumor Hospital, Medical College of Soochow University, Changzhou, Jiangsu 213002, P.R. China, Hepatic Surgery Center, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, P.R. China, Hepatic Surgery Center, The Third Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510630, P.R. China, Hepatobiliary Surgery Center, The Affiliated Ningbo No. 2 Hospital, Ningbo University School of Medicine, Ningbo, Zhejiang 315010, P.R. China
Pages: 1164-1166
|
Published online on: July 17, 2014

https://doi.org/10.3892/etm.2014.1850
Expand metrics +

Abstract

Graft versus host disease (GVHD) is an uncommon complication following liver transplantation. In the present case report, a 53‑year‑old male hepatitis B virus carrier was diagnosed with primary liver cancer with post‑hepatitis cirrhosis. Preoperative cytomegalovirus (CMV), Epstein‑Barr virus, coxsackievirus, herpes simplex virus and autoimmune antibody series were negative. Preoperative human leukocyte antigen type was also negative. Following classic orthotropic liver transplantation, postoperative treatment included immunosuppression therapy, infection protection, anti‑human immunodeficiency virus therapy and CMV infection protection therapy. Chemotherapy was initiated at day 16 following surgery. At day 26 following the transplantation, the patient developed a fever of unknown cause, and a scattered red rash was observed behind the left ear and on the neck. The patient presented with a fever of unknown cause, rash, symptoms of the digestive tract, leukocytopenia and pancytopenia. A diagnosis of GVHD was confirmed following a skin biopsy. Symptomatic therapies, including antivirals, anti‑anaphylaxis drugs and steroids were administered. However, the patient succumbed to infection, acute respiratory distress syndrome and multiple organ failure at day 46 following surgery. Therefore, an effective therapeutic strategy for the treatment of GVHD following liver transplantation is yet to be established, and further research is required prior to such a regimen being developed.

View Figures

View References

1	Thin L, Macquillan G, Adams L, et al: Acute graft-versus-host disease after liver transplant: novel use of etanercept and the role of tumor necrosis factor alpha inhibitors. Liver Transpl. 15:421–426. 2009. View Article : Google Scholar : PubMed/NCBI
2	Christopeit M, Schütte V, Theurich S, Weber T, Grothe W and Behre G: Rituximab reduces the incidence of acute graft-versus-host disease. Blood. 113:3130–3131. 2009. View Article : Google Scholar : PubMed/NCBI
3	D’Asaro M, Salerno A, Dieli F and Caccamo N: Analysis of memory and effector CD8⁺ T cell subsets in chronic graft-versus-host disease. Int J Immunopathol Pharmacol. 22:195–205. 2009.
4	Rezvani AR and Storb RF: Prevention of graft-vs. -host disease. Expert Opin Pharmacother. 13:1737–1750. 2012. View Article : Google Scholar : PubMed/NCBI
5	Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J and Thomas ED: 1994 consensus conference on acute GVHD grading. Bone Marrow Transplant. 15:825–828. 1995.PubMed/NCBI
6	Foley JE, Jung U, Miera A, et al: Ex vivo rapamycin generates donor Th2 cells that potently inhibit graft-versus-host disease and graft-versus-tumor effects via an IL-4-dependent mechanism. J Immunol. 175:5732–5743. 2005. View Article : Google Scholar : PubMed/NCBI
7	Wilson J, Cullup H, Lourie R, et al: Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease. J Exp Med. 206:387–398. 2009. View Article : Google Scholar : PubMed/NCBI
8	Ratanatharathorn V, Nash RA, Przepiorka D, et al: Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 92:2303–2314. 1998.
9	Busca A, Saroglia EM, Lanino E, et al: Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplant. 25:1067–1071. 2000. View Article : Google Scholar : PubMed/NCBI
10	Stewart BL, Storer B, Storek J, et al: Duration of immunosuppressive treatment for chronic graft-versus-host disease. Blood. 104:3501–3506. 2004. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Graft versus host disease following liver transplantation: A case report

This article is mentioned in:

Abstract

Figure 1

Related Articles